Investigation of metallodrug–protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS)

This publication has 23 references indexed in Scilit:

• ICP-MS for elemental speciation studies
  Microchimica Acta, 1998
• Analysis for metallothioneins using coupled techniques
  Talanta, 1998
• Identification of Inorganic Elements in Proteins in Human Serum and in DNA Fragments by Size Exclusion Chromatography and Inductively Coupled Plasma Mass Spectrometry with a Magnetic Sector Mass Spectrometer
  Journal of the American Chemical Society, 1998
• Development of an HPLC–ICP–MS method for the determination of platinum species from new anti-tumour drugs
  Analytical Proceedings including Analytical Communications, 1994
• Determination of gold-based antiarthritis drugs and their metabolites in urine by reversed-phase ion-pair chromatography with ICP-MS detection
  Journal of Pharmaceutical and Biomedical Analysis, 1992
• Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA
  Journal of the American Chemical Society, 1990
• Chromatography with Metal Specific Detection of Urine Samples from an Arthritis Patient on Auranofin Therapy
  Journal of Liquid Chromatography, 1990
• Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug
  Chemico-Biological Interactions, 1989
• Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications
  European Journal of Cancer and Clinical Oncology, 1982
• Pharmacokinetics of intact cisplatin in plasma. Infusion versus bolus dosing
  International Journal of Pharmaceutics, 1982